Validation of a Hypertension Education Program
Validation of the Hypertension Education Program of the German Hypertension League (DHL©) "My Blood Pressure - OK!"
1 other identifier
interventional
134
1 country
1
Brief Summary
The primary purpose of this study is to assess the effect of participating in the interactive hypertension education program of the German Hypertension League (DHL©) "My blood pressure - OK!" on office systolic blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 4, 2016
CompletedFirst Posted
Study publicly available on registry
February 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedFebruary 8, 2016
February 1, 2016
11 months
February 4, 2016
February 5, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Office systolic blood pressure (mmHg)
6 months
Secondary Outcomes (8)
Office diastolic blood pressure (mmHg)
6 months
Self-measured systolic and diastolic blood pressure (mmHg)
6 months
24-hour ambulatory blood pressure monitoring (mmHg)
6 months
Body Mass Index (kg per m2)
6 months
Physical activity (hours per week)
6 months
- +3 more secondary outcomes
Study Arms (2)
Education program
OTHERGroup of patients participating in the interactive hypertension education program of the DHL© "My blood pressure - OK!"
Controls
NO INTERVENTIONGroup of patients not participating in the interactive hypertension education program of the DHL© "My blood pressure - OK!" ("usual care")
Interventions
Eligibility Criteria
You may qualify if:
- \> 21 years of age
- Primary arterial hypertension
- Office blood pressure between 140/90 mmHg and 160/100 mmHg
You may not qualify if:
- Participation in another clinical study
- Unstable clinical condition
- Secondary arterial hypertension
- Dementia
- Major disability (modified Rankin-Scale \> 4)
- Severe chronic kidney disease (serum creatinine \> 2.0 mg/dL or estimated glomerular filtration rate \< 40 ml/min/1.73m2)
- Liver disease including history of hepatic encephalopathy, esophageal varices or portacaval shunt
- History of gastrointestinal operation or disease with a potential influence on drug absorption
- Allergy or other contraindications against drugs given during the study
- History of non-compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Herz- und Diabeteszentrum Ruhr-Universität Bochum
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reinhold Kreutz, Professor
Charite University, Berlin, Germany
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 4, 2016
First Posted
February 8, 2016
Study Start
August 1, 2015
Primary Completion
July 1, 2016
Last Updated
February 8, 2016
Record last verified: 2016-02